skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 310  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The extracellular matrix modulates the hallmarks of cancer
Material Type:
Article
Add to My Research

The extracellular matrix modulates the hallmarks of cancer

EMBO reports, 2014-12, Vol.15 (12), p.1243-1253 [Peer Reviewed Journal]

2014 The Authors ;2014 The Authors. ;2014 The Authors 2014 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201439246 ;PMID: 25381661 ;CODEN: ERMEAX

Full text available

2
Exosomes and other extracellular vesicles in host-pathogen interactions
Material Type:
Article
Add to My Research

Exosomes and other extracellular vesicles in host-pathogen interactions

EMBO reports, 2015-01, Vol.16 (1), p.24-43 [Peer Reviewed Journal]

2014 The Authors ;2014 The Authors. ;2014 The Authors 2014 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201439363 ;PMID: 25488940 ;CODEN: ERMEAX

Full text available

3
The steps from translatable to translational research
Material Type:
Article
Add to My Research

The steps from translatable to translational research

EMBO reports, 2014-11, Vol.15 (11), p.1107-1108 [Peer Reviewed Journal]

2014 The Author ;2014 The Author 2014 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201439587 ;PMID: 25296643 ;CODEN: ERMEAX

Full text available

4
Targeting senescent cells in translational medicine
Material Type:
Article
Add to My Research

Targeting senescent cells in translational medicine

EMBO molecular medicine, 2019-12, Vol.11 (12), p.e10234-n/a [Peer Reviewed Journal]

2019 The Authors. Published under the terms of the CC BY 4.0 license ;2019 The Authors. Published under the terms of the CC BY 4.0 license. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201810234 ;PMID: 31746100

Full text available

5
Genetically engineered mouse models in oncology research and cancer medicine
Material Type:
Article
Add to My Research

Genetically engineered mouse models in oncology research and cancer medicine

EMBO molecular medicine, 2017-02, Vol.9 (2), p.137-153 [Peer Reviewed Journal]

2016 The Authors. Published under the terms of the CC BY 4.0 license ;2016 The Authors. Published under the terms of the CC BY 4.0 license. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201606857 ;PMID: 28028012

Full text available

6
Dedifferentiation and reprogramming: origins of cancer stem cells
Material Type:
Article
Add to My Research

Dedifferentiation and reprogramming: origins of cancer stem cells

EMBO reports, 2014-03, Vol.15 (3), p.244-253 [Peer Reviewed Journal]

2014 The Authors ;2014 The Authors 2014 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.1002/embr.201338254 ;PMID: 24531722 ;CODEN: ERMEAX

Full text available

7
Investigating the zoonotic origin of the West African Ebola epidemic
Material Type:
Article
Add to My Research

Investigating the zoonotic origin of the West African Ebola epidemic

EMBO molecular medicine, 2015-01, Vol.7 (1), p.17-23 [Peer Reviewed Journal]

2014 The Authors. Published under the terms of the CC BY 4.0 license ;2014 The Authors. Published under the terms of the CC BY 4.0 license. ;2015. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 The Authors. Published under the terms of the CC BY 4.0 license 2014 ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201404792 ;PMID: 25550396

Full text available

8
Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure
Material Type:
Article
Add to My Research

Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure

EMBO reports, 2015-03, Vol.16 (3), p.280-296 [Peer Reviewed Journal]

2015 Novartis Institutes for BioMedical Research ;2015 Novartis Institutes for BioMedical Research. ;2015 Novartis Institutes for BioMedical Research 2015 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201439949 ;PMID: 25680965 ;CODEN: ERMEAX

Full text available

9
Ubiquitin in the immune system
Material Type:
Article
Add to My Research

Ubiquitin in the immune system

EMBO reports, 2014-01, Vol.15 (1), p.28-45 [Peer Reviewed Journal]

2014 The Authors. ;2014 The Authors. 2014 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.1002/embr.201338025 ;PMID: 24375678 ;CODEN: ERMEAX

Full text available

10
Faecal microbiota transplantation protects against radiation‐induced toxicity
Material Type:
Article
Add to My Research

Faecal microbiota transplantation protects against radiation‐induced toxicity

EMBO molecular medicine, 2017-04, Vol.9 (4), p.448-461 [Peer Reviewed Journal]

2017 The Authors. Published under the terms of the CC BY 4.0 license ;2017 The Authors. Published under the terms of the CC BY 4.0 license. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201606932 ;PMID: 28242755

Full text available

11
IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
Material Type:
Article
Add to My Research

IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment

EMBO molecular medicine, 2016-09, Vol.8 (9), p.1099-1112 [Peer Reviewed Journal]

2016 The Authors. Published under the terms of the CC BY 4.0 license ;2016 The Authors. Published under the terms of the CC BY 4.0 license. ;COPYRIGHT 2016 John Wiley & Sons, Inc. ;2016. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201606413 ;PMID: 27520969

Full text available

12
The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non‐coding RNA and synonymous mutations
Material Type:
Article
Add to My Research

The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non‐coding RNA and synonymous mutations

EMBO molecular medicine, 2016-05, Vol.8 (5), p.442-457 [Peer Reviewed Journal]

2016 The Authors. Published under the terms of the CC BY 4.0 license ;2016 The Authors. Published under the terms of the CC BY 4.0 license. ;2016. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201506055 ;PMID: 26992833

Full text available

13
Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
Material Type:
Article
Add to My Research

Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives

EMBO molecular medicine, 2019-03, Vol.11 (3), p.n/a [Peer Reviewed Journal]

2019 The Author. Published under the terms of the CC BY 4.0 license ;2019 The Author. Published under the terms of the CC BY 4.0 license. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201809958 ;PMID: 30670463

Full text available

14
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
Material Type:
Article
Add to My Research

Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy

EMBO molecular medicine, 2015-08, Vol.7 (8), p.1063-1076 [Peer Reviewed Journal]

2015 Cancer Research UK Beatson Institute. Published under the terms of the CC BY 4.0 license ;2015 Cancer Research UK Beatson Institute. Published under the terms of the CC BY 4.0 license. ;2015. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Cancer Research UK Beatson Institute. Published under the terms of the CC BY 4.0 license 2015 ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201404827 ;PMID: 26077591

Full text available

15
Effects of inflammation on stem cells: together they strive?
Material Type:
Article
Add to My Research

Effects of inflammation on stem cells: together they strive?

EMBO reports, 2015-04, Vol.16 (4), p.416-426 [Peer Reviewed Journal]

2015 The Authors ;2015 The Authors. ;2015 The Authors 2015 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201439702 ;PMID: 25739812 ;CODEN: ERMEAX

Full text available

16
VEGF‐C is required for intestinal lymphatic vessel maintenance and lipid absorption
Material Type:
Article
Add to My Research

VEGF‐C is required for intestinal lymphatic vessel maintenance and lipid absorption

EMBO molecular medicine, 2015-11, Vol.7 (11), p.1418-1425 [Peer Reviewed Journal]

2015 The Authors. Published under the terms of the CC BY 4.0 license ;2015 The Authors. Published under the terms of the CC BY 4.0 license. ;2015. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Published under the terms of the CC BY 4.0 license 2015 ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201505731 ;PMID: 26459520

Full text available

17
MicroRNA mimicry blocks pulmonary fibrosis
Material Type:
Article
Add to My Research

MicroRNA mimicry blocks pulmonary fibrosis

EMBO molecular medicine, 2014-10, Vol.6 (10), p.1347-1356 [Peer Reviewed Journal]

2014 miRagen Therapeutics Published under the terms of the CC BY 4.0 license ;2014 miRagen Therapeutics Published under the terms of the CC BY 4.0 license. ;COPYRIGHT 2014 John Wiley & Sons, Inc. ;2014 miRagen Therapeutics. Published under the terms of the CC BY 4.0 license 2014 ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201303604 ;PMID: 25239947

Full text available

18
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Material Type:
Article
Add to My Research

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

EMBO molecular medicine, 2010-05, Vol.2 (5), p.146-158 [Peer Reviewed Journal]

Copyright © 2010 EMBO Molecular Medicine ;Copyright John Wiley & Sons, Inc. May 2010 ;Copyright © 2010 EMBO Molecular Medicine 2010 ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.1002/emmm.201000070 ;PMID: 20432502

Full text available

19
ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth
Material Type:
Article
Add to My Research

ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth

EMBO molecular medicine, 2017-02, Vol.9 (2), p.198-218 [Peer Reviewed Journal]

2016 Cancer Research UK Beatson Institute. Published under the terms of the CC BY 4.0 license ;2016 Cancer Research UK Beatson Institute. Published under the terms of the CC BY 4.0 license. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201606743 ;PMID: 28031255

Full text available

20
Positive feedback regulation of type I interferon by the interferon-stimulated gene STING
Material Type:
Article
Add to My Research

Positive feedback regulation of type I interferon by the interferon-stimulated gene STING

EMBO reports, 2015-02, Vol.16 (2), p.202-212 [Peer Reviewed Journal]

2015 The Authors ;2015 The Authors. ;2015 The Authors 2015 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201439366 ;PMID: 25572843 ;CODEN: ERMEAX

Full text available

Results 1 - 20 of 310  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2005  (10)
  2. 2005 To 2007  (47)
  3. 2008 To 2010  (78)
  4. 2011 To 2014  (91)
  5. After 2014  (85)
  6. More options open sub menu

Searching Remote Databases, Please Wait